Nirav C Patel
Overview
Explore the profile of Nirav C Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DSilva L, Jarral O, Pupovac S, Tseng J, Patel N, Scheinerman S, et al.
Multimed Man Cardiothorac Surg
. 2025 Mar;
2025.
PMID: 40052594
This 27-year-old female patient is undergoing a reoperation for a recurrent subaortic membrane causing significant left ventricular outflow obstruction. The re-sternotomy is uneventful and cardiopulmonary bypass is established. The left...
2.
Mehaffey J, Strobel R, Kramer B, OGara P, Mack M, Patel N, et al.
Semin Thorac Cardiovasc Surg
. 2025 Feb;
PMID: 40015657
No abstract available.
3.
Jarral O, Pupovac S, Tseng J, Kliger C, Pirelli L, Dholakia K, et al.
JTCVS Tech
. 2024 Oct;
27:73-75.
PMID: 39478890
No abstract available.
4.
Newman J, Jarral O, Kim M, Brinster D, Singh V, Scheinerman S, et al.
Ann Cardiothorac Surg
. 2024 Oct;
13(5):425-435.
PMID: 39434979
Background: Hybrid coronary revascularization (HCR) is a well-established technique for treating multi-vessel coronary disease. There remains a paucity of discussion assessing the efficacy of HCR with respect to the timing...
5.
Newman J, Lambert D, Pupovac S, Patel N
Ann Cardiothorac Surg
. 2024 Oct;
13(5):455-457.
PMID: 39434976
No abstract available.
6.
Willard R, Scheinerman J, Pupovac S, Patel N
Ann Thorac Surg
. 2024 Apr;
118(2):318-328.
PMID: 38677447
Hybrid coronary revascularization (HCR) combines a minimally invasive surgical approach with percutaneous coronary intervention (PCI) for the treatment of multivessel coronary artery disease. Despite decades of use, widespread acceptance has...
7.
Iribarne A, Alabbadi S, Moskowitz A, Ailawadi G, Badhwar V, Gillinov M, et al.
J Am Coll Cardiol
. 2024 Apr;
83(17):1656-1668.
PMID: 38658105
Background: Tricuspid valve annuloplasty (TA) during mitral valve repair (MVr) is associated with increased risk of permanent pacemaker (PPM) implantation, but the magnitude of risk and long-term clinical consequences have...
8.
Varrone M, Sarmiento I, Pirelli L, Brinster D, Singh V, Kim M, et al.
Innovations (Phila)
. 2022 Nov;
17(6):521-527.
PMID: 36424729
Objective: We have routinely utilized minimally invasive direct coronary artery bypass (MIDCAB) for revascularization of the left anterior descending (LAD) coronary artery. We examined how this procedure has evolved. Methods:...
9.
Patel N, Macoskey A
Ann Cardiothorac Surg
. 2022 Oct;
11(5):510-524.
PMID: 36237594
Robotic mitral valve (MV) repair is an alternative approach to traditional MV repair via median sternotomy. There is a rich history of innovation embedded within robotic MV surgery. Since the...
10.
Bowdish M, Barkauskas C, Overbey J, Gottlieb R, Osman K, Duggal A, et al.
Am J Respir Crit Care Med
. 2022 Sep;
207(3):261-270.
PMID: 36099435
There are limited therapeutic options for patients with coronavirus disease (COVID-19)-related acute respiratory distress syndrome with inflammation-mediated lung injury. Mesenchymal stromal cells offer promise as immunomodulatory agents. Evaluation of efficacy...